Antiviral treatment causes a unique mutational signature in cancers of transplantation recipients.

MLA

de Kanter, Jurrian K., et al. “Antiviral Treatment Causes a Unique Mutational Signature in Cancers of Transplantation Recipients.” Cell Stem Cell, vol. 28, no. 10, Oct. 2021, p. 1726. EBSCOhost, https://doi.org/10.1016/j.stem.2021.07.012.

APA

de Kanter, J. K., Peci, F., Bertrums, E., Rosendahl Huber, A., van Leeuwen, A., van Roosmalen, M. J., Manders, F., Verheul, M., Oka, R., Brandsma, A. M., Bierings, M., Belderbos, M., & van Boxtel, R. (2021). Antiviral treatment causes a unique mutational signature in cancers of transplantation recipients. Cell Stem Cell, 28(10), 1726. https://doi.org/10.1016/j.stem.2021.07.012

Chicago

de Kanter, Jurrian K, Flavia Peci, Eline Bertrums, Axel Rosendahl Huber, Anaïs van Leeuwen, Markus J van Roosmalen, Freek Manders, et al. 2021. “Antiviral Treatment Causes a Unique Mutational Signature in Cancers of Transplantation Recipients.” Cell Stem Cell 28 (10): 1726. doi:10.1016/j.stem.2021.07.012.